RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Vectura Group Stock

Vectura Group ROCE 2024

Vectura Group ROCE

0

Ticker

VEC.L

ISIN

GB00BKM2MW97

WKN

A2PTCY

In 2024, Vectura Group's return on capital employed (ROCE) was 0, a 0% increase from the 0 ROCE in the previous year.

Vectura Group Aktienanalyse

What does Vectura Group do?

The Vectura Group PLC is a British company specializing in the development of inhalable medications. The company was founded in 1997 and is headquartered in Chippenham, England. History: Initially, Vectura focused on the development of products for the treatment of asthma and chronic obstructive pulmonary disease (COPD). In 2014, the company acquired competitor Skyepharma, expanding its product range to include a wider spectrum of inhalable medications and active ingredients. Business Model: Vectura's business model is based on collaborating with its partners to develop inhalable therapies and active ingredients. The company itself acts as a service provider, offering support to the pharmaceutical industry in the development of new solutions. Vectura has a wide range of technologies and expertise to offer its customers tailored solutions. Divisions: Vectura is divided into four different business units. "Inhaled Therapies" offers solutions for inhaling medications, including inhalers equipped with special propellants to deliver the active ingredients directly to the lungs. The "Royalty-Driven Products" division includes products for which Vectura holds licenses and benefits from the sales of these products. In the "Device Services" division, the company offers development and design services for inhalable therapies. Finally, Vectura also has a research department referred to as "New Product Opportunities," where the company works on the development of new technologies and therapies. Products: Vectura's key products include treatments for asthma and COPD, such as the inhaler Flutiform and the medication Seebri. The company also offers inhalable therapies for other diseases, such as cystic fibrosis and pulmonary hypertension. In addition to medical applications, Vectura also develops more sustainable inhalers and devices that do not rely on chlorofluorocarbons (CFCs) or other environmentally harmful propellants. Conclusion: Vectura has established itself as one of the leading companies in the field of inhalable medications. The company offers tailored solutions for its customers and invests in the development of new technologies to enhance inhalation therapy. Vectura has expanded its portfolio in recent years through the acquisition of Skyepharma and aims to further expand its market position. Vectura Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Vectura Group's Return on Capital Employed (ROCE)

Vectura Group's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Vectura Group's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Vectura Group's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Vectura Group’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Vectura Group stock

What is the ROCE (Return on Capital Employed) of Vectura Group this year?

The ROCE of Vectura Group is 0 undefined this year.

How has the ROCE (Return on Capital Employed) of Vectura Group developed compared to the previous year?

The ROCE of Vectura Group has increased by 0% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Vectura Group?

A high Return on Capital Employed (ROCE) indicates that Vectura Group has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Vectura Group?

A low ROCE (Return on Capital Employed) can indicate that Vectura Group has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Vectura Group impact the company?

An increase in the ROCE of Vectura Group can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Vectura Group affect the company?

A decrease in ROCE of Vectura Group can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Vectura Group?

Some factors that can affect Vectura Group's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Vectura Group so important for investors?

The ROCE of Vectura Group is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Vectura Group take to improve the ROCE?

To improve the ROCE, Vectura Group can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Vectura Group pay?

Over the past 12 months, Vectura Group paid a dividend of 0.06 GBP . This corresponds to a dividend yield of about 3.64 %. For the coming 12 months, Vectura Group is expected to pay a dividend of 0.99 GBP.

What is the dividend yield of Vectura Group?

The current dividend yield of Vectura Group is 3.64 %.

When does Vectura Group pay dividends?

Vectura Group pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Vectura Group?

Vectura Group paid dividends every year for the past 5 years.

What is the dividend of Vectura Group?

For the upcoming 12 months, dividends amounting to 0.99 GBP are expected. This corresponds to a dividend yield of 60.07 %.

In which sector is Vectura Group located?

Vectura Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Vectura Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Vectura Group from 6/11/2021 amounting to 0.19 GBP, you needed to have the stock in your portfolio before the ex-date on 6/1/2021.

When did Vectura Group pay the last dividend?

The last dividend was paid out on 6/11/2021.

What was the dividend of Vectura Group in the year 2023?

In the year 2023, Vectura Group distributed 0.996 GBP as dividends.

In which currency does Vectura Group pay out the dividend?

The dividends of Vectura Group are distributed in GBP.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Vectura Group stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Vectura Group

Our stock analysis for Vectura Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Vectura Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.